Prepare to Cry, Laugh, Shout . . . ASCO Has Arrived
Recap - The first new data out of ASCO, which officially started this Friday afternoon, took Bristol-Myers Squibb (BMY) down 7% late in the trading session For … Continue Reading
Read NowRecap
Get Our Top Picks In Biotech All Year with $100 Off
Recap - For this Memorial Day and a long weekend with family & friends, we’re offering YOU $100 off an annual subscription to our premier investing newsletter – PropThink … Continue Reading
Read NowNew Hiiiiiighs for the Market
Recap - Last week’s biotech recap covered the release of briefing documents from Vertex Pharmaceuticals’ (VRTX) advisory panel, which took place this Tuesday. The FDA’s Pulmonary-Allergy Drugs Advisory Committee voted … Continue Reading
Read NowStocks had a Fine Finish to a Rough Week
Recap - After a mostly red week, stocks gapped higher Friday morning with the latest jobs report. The jobless rate fell to 5.4%, the lowest since 2008, and a … Continue Reading
Read NowOne Cool Datapoint for Battered Healthcare Investors
Recap - The biotech sector slipped all week before some green into Friday’s close. These dips are beginning to feel like the norm, though with every fresh … Continue Reading
Read NowWhat a Friday!
Recap - Perhaps of most interest this week to long-time PropThink readers, Innate Pharma (IPH.PA)(IPHYF) took on AstraZeneca (AZN) as partner for the anti-NKG2A antibody IPH2201 on Friday morning, … Continue Reading
Read NowHealthcare Investors are Getting Ready for Back-to-Back Oncology Conferences
Recap - The first big news ahead of the American Association for Cancer Research’s (AACR) annual conference hit on Friday morning when Bristol-Myers Squibb (BMY) reported that … Continue Reading
Read Now